Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Announcement Summary Entity name BCAL DIAGNOSTICS LIMITED Date of this announcement Wednesday November 18, 2026 The +securities the subject of this notification are: +Securities issued as part of a...
Notification regarding unquoted securities - BDX
Filed with ASX · · 5 pages · English
Summary by 6ix AI
BCAL Diagnostics Limited has filed a notification regarding the issue of unquoted equity securities, specifically convertible notes. These securities are not intended to be quoted on the ASX. The announcement also mentions further drawdowns under the convertible note facility are expected to complete the transaction.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Change of Director's Interest Notice
- BCAL Expands Breast Cancer Biomarker Program
- Notification of cessation of securities - BDX
- Application for quotation of securities - BDX
- GSS - Panel Receives Application
Later from BCAL Diagnostics
All BCAL Diagnostics news releasesFollow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics